Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks
- PMID: 33765237
- DOI: 10.1007/s12640-021-00356-8
Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks
Abstract
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5-15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.
Keywords: Animal models; Dopamine; Epigenetics; Parkinsonian; Pesticides; Toxins.
Similar articles
-
Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88. Curr Protoc Neurosci. 2020. PMID: 32049438 Review.
-
CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.Neurotox Res. 2016 Apr;29(3):364-80. doi: 10.1007/s12640-015-9557-5. Epub 2015 Sep 24. Neurotox Res. 2016. PMID: 26403659
-
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.Brain Res. 2016 Sep 1;1646:354-365. doi: 10.1016/j.brainres.2016.05.038. Epub 2016 May 24. Brain Res. 2016. PMID: 27233809
-
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.Neurobiol Dis. 2021 Jun;153:105312. doi: 10.1016/j.nbd.2021.105312. Epub 2021 Feb 23. Neurobiol Dis. 2021. PMID: 33636387 Free PMC article.
-
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.J Neural Transm (Vienna). 2018 Mar;125(3):337-363. doi: 10.1007/s00702-017-1774-z. Epub 2017 Aug 31. J Neural Transm (Vienna). 2018. PMID: 28861737 Free PMC article. Review.
Cited by
-
The Parkinson-Associated Toxin Paraquat Shifts Physiological α-Synuclein Tetramers toward Monomers That Can Be Calpain-Truncated and Form Oligomers.Am J Pathol. 2023 May;193(5):520-531. doi: 10.1016/j.ajpath.2023.01.010. Epub 2023 Feb 9. Am J Pathol. 2023. PMID: 36773784 Free PMC article.
-
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.Behav Brain Funct. 2025 May 31;21(1):14. doi: 10.1186/s12993-025-00279-w. Behav Brain Funct. 2025. PMID: 40450319 Free PMC article. Review.
-
Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.Neurochem Res. 2024 Aug;49(8):1926-1944. doi: 10.1007/s11064-024-04177-x. Epub 2024 Jun 1. Neurochem Res. 2024. PMID: 38822985 Review.
-
Evaluating Motor Dysfunction and Oxidative Stress Induced by Trichloroethylene in Wistar Rats.Methods Mol Biol. 2024;2761:499-510. doi: 10.1007/978-1-0716-3662-6_34. Methods Mol Biol. 2024. PMID: 38427258
-
Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets.Biomed Pharmacother. 2022 May;149:112812. doi: 10.1016/j.biopha.2022.112812. Epub 2022 Mar 12. Biomed Pharmacother. 2022. PMID: 35290887 Free PMC article. Review.
References
-
- Acker Carmine I, Luchese C, Prigol M, Nogueira CW (2009) Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: Involvement of Na+K+ ATPase activity. Neurosci Lett 455(3):168–172. https://doi.org/10.1016/j.neulet.2009.03.069 - DOI - PubMed
-
- Acker Carmine I, Souza ACG, Pinton S, da Rocha JT, Friggi CA, Zanella R, Nogueira CW (2011) Repeated malathion exposure induces behavioral impairment and AChE activity inhibition in brains of rat pups. Ecotoxicol Environ Saf 74(8):2310–2315. https://doi.org/10.1016/j.ecoenv.2011.07.035 - DOI - PubMed
-
- Ahmed H, Abushouk AI, Gabr M, Negida A, Abdel-Daim MM (2017) Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations. Biomed Pharmacother 90:638–649. https://doi.org/10.1016/j.biopha.2017.03.100 - DOI
-
- Allen JL, Liu X, Weston D, Conrad K, Oberdörster G, Cory-Slechta DA (2014) Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson’s disease phenotype in male mice. Neurotoxicology 41:80–88. https://doi.org/10.1016/J.NEURO.2014.01.004 - DOI - PubMed - PMC
-
- Allen MT, Levy LS (2013) Parkinson’s disease and pesticide exposure – a new assessment. Crit Rev Toxicol 43(6):515–534. https://doi.org/10.3109/10408444.2013.798719 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources